Skip to main content
How the US Food and Drug Administration’s approval of aducanumab for Alzheimer's disease has implication for oncology and beyond
Published Web Location
https://doi.org/10.1016/j.ejca.2021.08.012Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.